Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2014
05/29/2014US20140148457 Thiazole derivatives
05/29/2014US20140148446 Compounds that enable alternative mitochondrial electron transfer
05/29/2014US20140148442 Fast-dissolve dosage forms of 5-ht2c agonists
05/29/2014US20140148441 6-((s)-1--ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
05/29/2014US20140148438 Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
05/29/2014US20140148435 Azetidine and piperidine compounds useful as pde10 inhibitors
05/29/2014US20140148433 Bicyclic aza heterocycles, and use thereof
05/29/2014US20140148431 1,6- Diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
05/29/2014US20140148422 Treatment of glucose intolerance
05/29/2014US20140148421 Organic compounds
05/29/2014US20140148420 Combinations comprising antimuscarinic agents and pde4 inhibitors
05/29/2014US20140148408 Antimicrobial Compositions
05/29/2014US20140148400 Carbonic anhydrase inhibitors with antimetastatic activity
05/29/2014US20140148383 Entacapone for prevention and treatment of obesity and related metabolic diseases
05/29/2014US20140147529 Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
05/29/2014US20140147524 Truely Re'Vived
05/29/2014US20140147503 Pharmaceutical Composition Comprising Deferasirox
05/29/2014US20140147496 Composition and method for fertility therapy using nutritional supplements
05/29/2014US20140147491 Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glutamic acid
05/29/2014US20140147444 Selective binding agents of osteoprotegerin binding protein
05/29/2014US20140147443 Compositions and methods for diagnosing and treating cancer
05/29/2014US20140147441 Compositions containing alpha-1-antitrypsin and methods for use
05/29/2014US20140147428 Neurodegenerative disorders and muscle diseases implicating pufas
05/29/2014US20140147413 Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
05/29/2014US20140147412 Spiro compounds as hepatitis c virus inhibitors
05/29/2014US20140147401 Use of chitosans to increase nail growth rate
05/29/2014US20140147386 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
05/28/2014EP2735316A1 New therapeutic approaches for treating neuroinflammatory conditions
05/28/2014EP2735309A1 Pharmaceutical composition for the treatment of calcific tendinitis and/or calcific bursitis
05/28/2014EP2734237A2 Tumor selective chemokine modulation
05/28/2014EP2734236A2 Methods and compositions for treating asthma using anti-il-13 antibodies
05/28/2014CN103826632A 骨形成促进剂及其用途 Bone formation accelerator and use thereof
05/28/2014CN103826629A 恶性血液病的组合治疗 Combination therapy of hematological malignancies
05/28/2014CN103826624A 类风湿性关节炎等自身免疫疾病的处置的改善方法 Ways to improve the disposal of rheumatoid arthritis and other autoimmune diseases
05/28/2014CN103826621A 包含植物大麻素次大麻二酚(cbdv)和大麻二酚(cbd)的药物组合物 Comprising a plant cannabinoids cannabidiol times (cbdv) and cannabidiol (cbd) a pharmaceutical composition
05/28/2014CN103826607A 用于皮肤或毛发的uv防护剂的泡囊状载体体系的电荷给体 Charge for skin or hair uv protectant foam carrier system cystic donor
05/28/2014CN103816542A 一种含镇痛药和磷丙泊酚钠的药物组合物 The pharmaceutical compositions containing analgesics and phenol sodium phosphate propofol
05/28/2014CN103816541A ADP受体p2y12在血管生成中的应用 ADP receptor p2y12 application in angiogenesis
05/28/2014CN103816540A 降低β-抑制蛋白1与APH-1蛋白的结合的物质在制备防治神经退行性疾病药物中的应用 Reducing β- inhibit the binding protein 1 and the APH-1 protein substance prepared in the prevention and treatment of neurodegenerative diseases, drugs Application
05/28/2014CN102626518B 一种包载难溶性药物的泊洛沙姆/两亲性多糖混合胶束的制备和应用 A package contained insoluble drugs poloxamer / preparation and application of amphiphilic polysaccharide mixed micelles
05/28/2014CN102227227B 包含吡啶并[4，3-d]嘧啶衍生的HSP90抑制剂和HER2抑制剂的药物组合 Comprising pyrido [4,3-d] pyrimidine derivatives of the pharmaceutical composition HSP90 inhibitor and a HER2 inhibitor
05/28/2014CN102133393B 稳定性提高的酸性胰岛素制剂 To improve the stability of acidic insulin preparations
05/28/2014CN101378743B 以2-氨基-1,3-丙二醇衍生物为有效成分的炎症性肠疾病治疗剂及其在制备治疗或预防炎症性肠疾病的药物中的用途 2-amino-1,3-propanediol derivative as an active ingredient of a therapeutic agent for inflammatory bowel disease and their use in the manufacture of a medicament for the treatment or prevention of inflammatory bowel disease in
05/27/2014US8735428 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
05/27/2014US8735356 Anticonvulsant combination therapy
05/27/2014US8734785 Compositions to inhibit pathogenic growth
05/27/2014US8734783 Composition comprising probiotic bacteria for use in the treatment of immune disorders
05/27/2014US8734777 Heterocyclic antiviral compounds
05/27/2014US8734776 Mutants of IL-29
05/27/2014US8734775 Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments
05/27/2014US8734769 1L1RL-1 as a cardiovascular disease marker and therapeutic target
05/27/2014CA2726861C Devices, formulations, and methods for delivery of multiple beneficial agents
05/27/2014CA2647803C Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
05/27/2014CA2609188C Apo-2 ligand/trail formulations
05/27/2014CA2568750C Compositions and methods for treatment of neovascular diseases
05/27/2014CA2442080C A preparation for restenosis prevention
05/27/2014CA2371814C Trpm-2 antisense therapy
05/27/2014CA2298855C Interleukin-18 binding proteins, their preparation and use
05/27/2014CA2283143C Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
05/22/2014WO2014077409A1 Agent for mitigating side effect of sunitinib
05/22/2014WO2014077358A1 Radiation exposure treatment agent and radiation exposure treatment method
05/22/2014WO2014077244A1 Transdermal absorption sheet, and manufacturing method for same
05/22/2014WO2014076702A1 Combination treatment for amyotrophic lateral sclerosis (als)
05/22/2014WO2014076632A1 A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker
05/22/2014WO2014076453A1 Adrenergic agonists for use in treating liver damage
05/22/2014US20140142185 3-Benzyloxyphenyloxoacetic Acid Compounds for Reducing Uric Acid
05/22/2014US20140142174 Darunavir formulations
05/22/2014US20140142156 Non-Lactone Carbocyclic and Heterocyclic Antagonists and Agonists of Bacterial Quorum Sensing
05/22/2014US20140142145 Combinations comprising a dipeptidylpeptidase - iv inhibitor
05/22/2014US20140142140 Pharmaceutical composition for neurological disorders
05/22/2014US20140142139 Dihydropyrazole gpr40 modulators
05/22/2014US20140142134 Inhibitors of bacterial type iii secretion system
05/22/2014US20140142124 Compositions for Topical Application Having Androgenic Actions
05/22/2014US20140142118 Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
05/22/2014US20140142114 Anthelmintic compounds and compositions and method of using thereof
05/22/2014US20140142103 Methods and Compositions for Modulating Rad51 and Homologous Recombination
05/22/2014US20140142102 Cyclic amines as bromodomain inhibitors
05/22/2014US20140142099 Purinone Derivatives as Tyrosine Kinase Inhibitors
05/22/2014US20140142098 Triazolopyrazine
05/22/2014US20140142097 Pyridine-and pyrazine derivatives
05/22/2014US20140142087 INHIBITORS OF PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAP), INCLUDING D-PROPRANOLOL AND ANALOGS THEREOF, ALONE OR IN COMBINATION WITH DESIPRAMINE, FOR THE TREATMENT OF CANCERS THAT DEPEND ON THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ONCOGENIC VARIANTS THEREOF AND OTHER MEMBERS OF THE ErbB/HER FAMILY
05/22/2014US20140142085 Compounds for the treatment of hiv
05/22/2014US20140142072 Composition comprising a diindolylmethane and a retinoid to treat a skin condition
05/22/2014US20140142056 Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors
05/22/2014US20140142052 Phosphorylated polyols, pyrophosphates, and derivatives thereof having biological activity
05/22/2014US20140142043 Inhibition of drug resistant cancer cells
05/22/2014US20140142042 Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
05/22/2014US20140142023 Pharmaceutical Composition for Treating A Metabolic Syndrome
05/22/2014US20140141103 Methods of treating hepatitis
05/22/2014US20140141102 Trimegestone (tmg) for treatment of preterm birth
05/22/2014US20140141100 Compounds and Methods for Appetite Suppression and Weight Control
05/22/2014US20140141099 Drug discovery methods
05/22/2014US20140141088 Water-Soluble Anti-Inflammatory Cream with Natural Ingredients Base
05/22/2014US20140141086 Injectable Depot Compositions and Uses Thereof
05/22/2014US20140141082 Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses
05/22/2014US20140141080 Pharmaceutical compositions for the coordinated delivery of nsaids
05/22/2014US20140141071 Orally administrable liposomally encapsulated reduced glutathione, with n-o enhancing compounds for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
05/22/2014US20140141069 Beta-guanidinopropionic acid for the treatment of hypertension
05/22/2014US20140141060 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
05/22/2014US20140141010 Use of adsl activator to achieve glycemic control in mammals
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 1151